Equity · Healthcare
KMTS
NASDAQKestra Medical Technologies (KMTS)
This price chart is drawn by TradingView, from their own data, in an embed loaded from their servers.
- Market cap
- 1.4B USD
- Revenue, year to Apr 2026
- 95.1M USD
- EPS, diluted, year to Apr 2026
- −2.43 USD
- 52-week range
- 14.47 USD – 28 USD
- Avg volume
- 90.3K
as of Jul 17, 2026
Have Kestra Medical Technologies (KMTS) insiders bought or sold shares recently?
In the 90 days to 10 Nov 2026, Kestra Medical Technologies insiders reported 14 open-market sales and no purchases (SEC Form 4); none has bought on the open market since 26 Mar 2026.
Form 4, 90 days to 10 Nov 2026, newest reported trade 3 Nov 2026
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 03 Nov 2026 | Moran Timothy P.Chief Business Officer | Sell | 3,192 | 94K USD |
| 29 Oct 2026 | Mahboob VaseemChief Financial Officer | Sell | 4,788 | 147K USD |
| 28 Oct 2026 | Mahboob VaseemChief Financial Officer | Sell | 39,903 | 1.2M USD |
| 27 Oct 2026 | Umberger Traci SSee Remarks | Sell | 30,000 | 901K USD |
| 27 Oct 2026 | Mahboob VaseemChief Financial Officer | Sell | 34,809 | 1.0M USD |
| 21 Oct 2026 | Umberger Traci SSee Remarks | Sell | 100,000 | 2.7M USD |
| 20 Oct 2026 | Webster Brian DanielSee Remarks | Sell | 15,000 | 443K USD |
| 30 Sep 2026 | COHEN RAYMOND WDirector | Sell | 3,330 | 98K USD |
| 21 Sep 2026 | Kwo ElizabethDirector | Sell | 4,010 | 97K USD |
| 08 Sep 2026 | Reilly Kevin CDirector | Sell | 2,932 | 74K USD |
| 08 Sep 2026 | Ladone Mary KayDirector | Sell | 3,908 | 98K USD |
| 08 Sep 2026 | Schwartz Jeffrey LawrenceDirector | Sell | 3,890 | 98K USD |
| Sold | 14 open-market sales | 266,456 | $7.59M |
Showing the 12 most recent of 14 open-market trades in this window. The figures above count all of them.
11 other filings in the window: grants, exercises, tax withholding and transfers, not trades
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 29 Oct 2026 | Mahboob VaseemChief Financial Officer | Option exercise | 4,788 | 81K USD |
| 28 Oct 2026 | Mahboob VaseemChief Financial Officer | Option exercise | 39,903 | 678K USD |
| 27 Oct 2026 | Umberger Traci SSee Remarks | Option exercise | 30,000 | 510K USD |
| 27 Oct 2026 | Mahboob VaseemChief Financial Officer | Option exercise | 34,809 | 592K USD |
| 21 Oct 2026 | Umberger Traci SSee Remarks | Option exercise | 100,000 | 1.7M USD |
| 09 Sep 2026 | Hanley ConorDirector | Award | 7,217 | |
| 09 Sep 2026 | Reilly Kevin CDirector | Award | 7,217 | |
| 09 Sep 2026 | Ladone Mary KayDirector | Award | 7,217 | |
| 09 Sep 2026 | Schwartz Jeffrey LawrenceDirector | Award | 7,217 | |
| 09 Sep 2026 | Kwo ElizabethDirector | Award | 7,217 | |
| 09 Sep 2026 | COHEN RAYMOND WDirector | Award | 7,217 |
Which funds hold Kestra Medical Technologies (KMTS)?
5 of the 45 institutional funds we track reported a Kestra Medical Technologies position for the quarter ended 30 Jun 2026 — a combined 20.6M USD; the latest of those filings landed 02 Sep 2026.
| Fund | Position | Shares | Value | Shares q/q |
|---|---|---|---|---|
| Point72 Asset Management | New position | 526,626 | 13.4M USD | |
| Millennium Management | Held (±25%) | 163,387 | 4.2M USD | −17.3% |
| Tudor Investment Corp | Added | 49,977 | 1.3M USD | +56.7% |
| Citadel Advisors | Added | 35,534 | 904K USD | +154.9% |
| AQR Capital Management | New position | 32,447 | 825K USD |
What has been filed or recorded for Kestra Medical Technologies (KMTS)?
The filings we hold for Kestra Medical Technologies, newest first: 9 fails-to-deliver days, 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 14 Oct 2026. No next earnings date is announced in SEC filings yet.
| And | ||||
|---|---|---|---|---|
| 14 Oct 2026 | Fails to deliver | Shares failed to deliver | 9 shares | 243 USD notional · <0.001% of shares out |
| 13 Oct 2026 | Fails to deliver | Shares failed to deliver | 72 shares | 2K USD notional · <0.001% of shares out |
| 08 Oct 2026 | Fails to deliver | Shares failed to deliver | 557 shares | 15K USD notional · 0.001% of shares out |
| 07 Oct 2026 | Fails to deliver | Shares failed to deliver | 941 shares | 26K USD notional · 0.002% of shares out |
| 02 Oct 2026 | Fails to deliver | Shares failed to deliver | 500 shares | 14K USD notional · 0.001% of shares out |
| 01 Oct 2026 | Fails to deliver | Shares failed to deliver | 69,926 shares | 2.0M USD notional · 0.117% of shares out |
| 30 Sep 2026 | Fails to deliver | Shares failed to deliver | 13,467 shares | 383K USD notional · 0.023% of shares out |
| 29 Sep 2026 | Fails to deliver | Shares failed to deliver | 4,869 shares | 137K USD notional · 0.008% of shares out |
| 28 Sep 2026 | Fails to deliver | Shares failed to deliver | 476 shares | 13K USD notional · 0.001% of shares out |
| 31 Jul 2026 | Quarterly earnings | Q1 2026 reported | EPS −0.75 USD | Revenue $31M |
| 31 Jul 2026 | Financials | Total assets | 347.4M USD | at period end |
| 31 Jul 2026 | Financials | Total equity incl. minority interest | 222.4M USD | at period end |
| 30 Apr 2026 | Annual report | FY 2026 reported | EPS −2.43 USD | Revenue $95M |
| 30 Apr 2026 | Financials | Revenue | 95.1M USD | fiscal year |
| 30 Apr 2026 | Financials | Net income | −131.6M USD | fiscal year |
| 30 Apr 2026 | Financials | Diluted EPS | −2.43 USD | fiscal year |
| 31 Jan 2026 | Quarterly earnings | Q3 2026 reported | EPS −0.61 USD | Revenue $25M |
| 31 Oct 2025 | Quarterly earnings | Q2 2025 reported | EPS −0.64 USD | Revenue $23M |
| 31 Jul 2025 | Quarterly earnings | Q1 2025 reported | EPS −0.50 USD | Revenue $19M |
| 30 Apr 2025 | Annual report | FY 2025 reported | EPS −5.13 USD | Revenue $60M |
| 31 Jan 2025 | Quarterly earnings | Q3 2026 reported | EPS −1.25 USD | Revenue $15M |
| 31 Oct 2024 | Quarterly earnings | Q2 2025 reported | EPS −1.19 USD | Revenue $15M |
What do people ask about Kestra Medical Technologies (KMTS)?
What is Kestra Medical Technologies’ market cap?1.4B
Kestra Medical Technologies is worth 1.4B USD by market value as of 17 Jul 2026, which is the share price times the shares on issue from its SEC filings.
What is Kestra Medical Technologies’ revenue?95.1M
Kestra Medical Technologies reported revenue of 95.1M USD for the year ended 30 Apr 2026, as filed with the SEC. See Filings
Have Kestra Medical Technologies insiders bought or sold shares recently?14 sales
In the 90 days to 10 Nov 2026, Kestra Medical Technologies insiders reported 14 open-market sales and no purchases (SEC Form 4); none has bought on the open market since 26 Mar 2026. A further 11 filings were grants, awards, gifts or exercises rather than open-market trades. See Insiders
Which funds own Kestra Medical Technologies?5 of 45
5 of the 45 funds we track reported a Kestra Medical Technologies position for the quarter ended 30 Jun 2026, per their SEC Form 13F filings. The largest reported positions were Point72 Asset Management, Millennium Management and Tudor Investment Corp. See Funds
When did Kestra Medical Technologies last report earnings?−0.75
Kestra Medical Technologies last reported earnings on 31 Jul 2026 for Q1 2026, with EPS of −0.75 USD; no next date is announced in SEC filings yet. See Filings
Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
References
- Finazonprior-day close, indicative (IEX-derived, not the official close)
- TradingViewthe price chart widget, drawn by TradingView from their own data
- SEC EDGARForm 4 filings (insider transactions)
- SEC EDGAR13F filings
- SECSEC fails-to-deliver (CNS) data
- SEC EDGARXBRL company facts, latest period ended 31 Jul 2026
- SEC EDGARreported earnings figures and scheduled report dates
- SEC EDGARValuation computed from SEC EDGAR filings